Meridian Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$294K Hold
1,122
– – 0.14% 119
2026
Q2
$282K Hold
1,122
– – 0.14% 124
2026
Q1
$244K Hold
1,122
– – 0.13% 128
2025
Q4
$256K Buy
1,122
+17
+2% +$3.87K 0.14% 121
2025
Q3
$256K Hold
1,105
– – 0.14% 115
2025
Q2
$205K Sell
1,105
-32
-3% -$5.95K 0.13% 127
2025
Q1
$238K Hold
1,137
– – 0.17% 103
2024
Q4
$202K Sell
1,137
-10
-0.9% -$1.84K 0.14% 118
2024
Q3
$227K Buy
+1,147
New +$214K 0.15% 120
2024
Q2
– Sell
-1,147
Closed -$209K – 121
2024
Q1
$209K Buy
+1,147
New +$198K 0.16% 119

Other funds holding ABBV

Meridian Financial's ABBV Position: Q3 2026 in Review

Meridian Financial held its AbbVie (ABBV) position steady in Q3 2026 at 1,122 shares worth $294K. The position accounts for 0.14% of the portfolio, ranked #119.

Meridian Financial first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Meridian Financial held 1,122 shares of AbbVie worth $294K as of Q3 2026.
  • Meridian Financial left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.14% of Meridian Financial's portfolio in Q3 2026, its #119 holding.
  • Meridian Financial first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Meridian Financial's 13F filing for Q3 2026, filed 14 Oct 2026.